![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0013.png)
conferenceseries
.com
Page 38
Notes:
Volume 7, Issue 6 (Suppl)
J Biotechnol Biomater, an open access journal
ISSN: 2155-952X
World Biotechnology 2017
December 04-05, 2017
2
nd
World Biotechnology Congress
December 04-05, 2017 | Sao Paulo, Brazil
Impact of biotechnology in Brazilian agriculture sector
Adriana Brondani
Conselho de Informações Sobre Biotecnologia, Brazil
B
razil is the second largest producer of biotech crops in the world. A strict regulatory environment has been playing a crucial role in
the rapid development and commercialization of biotech products in Brazil. The 2005 Biosafety Law defined security mechanisms
for genetic modified organisms (GMO) monitoring, establishing supervision procedures over the development, farming, production,
research and commercialization of transgenic seeds. As a consequence of a stablished regulatory framework on biosafety, over 300
biotech companies have been working in Brazil. These companies are focusing on a vast array of biotech areas such as human and
animal health, bioenergy and agriculture. Thanks to sustainable practices, to the use of technology and to committed farmers, Brazil
produces a significant share of food, fibers and renewable energies consumed all over the world. As a result from GMO adoption,
Brazil has increased agriculture production by 350% while its land use increased only by 50%, causing a clear impact on sustainability
and biodiversity preservation. Agribusiness carries on as a growing industry. According to data released by the National Supply
Company, Brazilian grain crop may reach a record production of up to 215 million tons in 2017. To reach this productivity and
competitiveness level, the application of scientific knowledge in agriculture is crucial. Thanks to the use and development of new
inputs, to the mechanization of the work in the fields and to the adoption of high-performance seeds developed by classical and
genetic breeding, we are now able to produce more.
Biography
Adriana Brondani has her expertise in Science Communication. She is the Executive Director of Council for Information on Biotechnology (CIB) since 2011. She is a
Biologist, and has completed her Master and PhD in Biochemistry and Molecular Biology. She has years of experience in research and teaching in hospital and education
institutions. Currently, she is a Professor of MBA in Agribusiness at Sao Paulo University and at the Brazilian Association of Nutrology (ABRAN).
adriana.brondani@cib.org.brAdriana Brondani, J Biotechnol Biomater 2017, 7:6 (Suppl)
DOI: 10.4172/2155-952X-C1-085